1,029 results on '"Reindl, Markus"'
Search Results
2. Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept
3. Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving Natalizumab
4. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
5. Factors and strategies affecting motor imagery ability in people with multiple sclerosis: a systematic review
6. Peripheral neuropathy and MOG-IgG: A clinical and neuropathological retrospective study
7. Peripheral inflammatory response in people after acute ischaemic stroke and isolated spontaneous cervical artery dissection
8. Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disorders
9. Anti-NMDA receptor encephalitis and MOG-associated demyelination – a case report with long-term follow-up and a systematic review
10. 12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
11. Actual and Imagined Music-Cued Gait Training in People with Multiple Sclerosis: A Double-Blind Randomized Parallel Multicenter Trial.
12. More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies
13. Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder
14. Myelin-oligodendrocyte glycoprotein antibody-associated disease
15. International MOGAD criteria
16. Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
17. Antibodies to MOG in CSF only: pathological findings support the diagnostic value
18. 6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
19. Presence of anti-neuronal antibodies in children with neurological disorders beyond encephalitis
20. MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
21. Combining specific task-oriented training with manual therapy to improve balance and mobility in patients after stroke: a mixed methods pilot randomised controlled trial.
22. Factors influencing the willingness to adopt telerehabilitation among rehabilitation professionals in Austria and Germany: a survey comparing data before and during COVID-19.
23. Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?
24. Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up
25. Cell-based assays for the detection of MOG antibodies: a comparative study
26. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
27. German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis
28. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
29. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers
30. High association of MOG-IgG antibodies in children with bilateral optic neuritis
31. A clinical approach to diagnosis of autoimmune encephalitis
32. Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern
33. Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
34. Antibody signatures in patients with histopathologically defined multiple sclerosis patterns
35. T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis
36. Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
37. Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models
38. New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseases
39. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
40. Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
41. Myelin oligodendrocyte glycoprotein antibodies in neurological disease
42. Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes
43. MOG‐IgG ‐Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox Vaccination
44. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5
45. Teaching NeuroImages: Bilateral optic neuritis
46. Combining specific task-oriented training with manual therapy to improve balance and mobility in patients after stroke: a mixed methods pilot randomised controlled trial
47. Factors influencing the willingness to adopt telerehabilitation among rehabilitation professionals in Austria and Germany: a survey comparing data before and during COVID-19
48. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF
49. High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis
50. Teaching NeuroImages: Bilateral optic neuritis: When to suspect anti-MOG antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.